10 months ago
CYTK
AnalystsGena WangGena Wang's Stock Forecasts
AnalystsGena Wang
Sectors:
Analyst Ranking
Bottom 5%
#5281 out of 5548 analysts
Average Return
-2.54%
Win Rate
40%71 out of 176
Risk vs Reward
Poor
Good
Gena Wang's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Beam Therapeutics IncBEAM | +315.20% | $23.02 | $95.58 | 2020-03-02 - 2021-03-01 | Strong Buy |
Moderna IncMRNA | +260.41% | $59.10 | $213.00 | 2020-06-08 - 2021-06-08 | Strong Buy |
4d Molecular Therapeutics IncFDMT | +229.22% | $3.08 | $10.14 | 2025-05-09 - 2026-05-08 | Strong Buy |
Cellectis SaCLLS | +180.85% | $1.41 | $3.96 | 2025-05-13 - 2026-05-12 | Strong Buy |
Biocryst Pharmaceuticals IncBCRX | +170.38% | $3.95 | $10.68 | 2020-05-05 - 2021-05-05 | Strong Buy |
Gena Wang Analyst Color
Get additional color on Gena Wang's coverage of popular stocks
a year ago
BCRX
a year ago
ALNY
a year ago
BMRN
a year ago
CLLS
2 years ago
VIR
3 years ago
SLDB
3 years ago
RGNX
3 years ago
SRPT
3 years ago
VRTX
3 years ago
LEGN
3 years ago
VRTX
3 years ago
LEGN
4 years ago
LEGN
Gena Wang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Regenxbio IncRGNX | 8 | Strong Buy | $12.00 | +79.64% | Maintains | 5 months ago |
Cytokinetics IncCYTK | 7 | Strong Buy | $95.00 | +55.15% | Maintains | 7 months ago |
Legend Biotech CorpLEGN | 8 | Strong Buy | $80.00 | +315.15% | Maintains | 9 months ago |
Ultragenyx Pharmaceutical IncRARE | 7 | Strong Buy | $50.00 | +219.49% | Maintains | a year ago |
4d Molecular Therapeutics IncFDMT | 3 | Strong Buy | $33.00 | +205.56% | Maintains | a year ago |
Moderna IncMRNA | 10 | Hold | $25.00 | -87.51% | Maintains | a year ago |
Intellia Therapeutics IncNTLA | 9 | Strong Buy | $14.00 | +24.89% | Maintains | a year ago |
Sangamo Therapeutics IncSGMO | 5 | Hold | $1.00 | +769.57% | Downgrades | a year ago |
Ptc Therapeutics IncPTCT | 17 | Hold | $68.00 | +12.23% | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 16 | Hold | $20.00 | +12.80% | Maintains | a year ago |
Vertex Pharmaceuticals IncVRTX | 18 | Hold | $414.00 | -20.98% | Maintains | a year ago |
Solid Biosciences IncSLDB | 8 | Strong Buy | $9.00 | +52.03% | Maintains | a year ago |
Biocryst Pharmaceuticals IncBCRX | 11 | Hold | $9.00 | +17.65% | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 8 | Strong Buy | $527.00 | +135.24% | Maintains | a year ago |
Ionis Pharmaceuticals IncIONS | 11 | Strong Buy | $95.00 | +121.29% | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 6 | Strong Buy | $80.00 | +42.98% | Maintains | a year ago |
Cellectis SaCLLS | 4 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Kodiak Sciences IncKOD | 10 | Hold | $17.00 | N/A | Upgrades | a year ago |
Avidity Biosciences IncRNAM | 4 | Strong Buy | $62.00 | N/A | Maintains | a year ago |
Crispr Therapeutics AgCRSP | 16 | Hold | $56.00 | N/A | Maintains | a year ago |
Beam Therapeutics IncBEAM | 10 | Hold | $21.00 | N/A | Maintains | a year ago |
Bluebird Bio IncBLUE | 10 | Strong Buy | $8.00 | N/A | Maintains | 2 years ago |
Vir Biotechnology IncVIR | 5 | Strong Buy | $31.00 | N/A | Maintains | 2 years ago |
Editas Medicine IncEDIT | 9 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Mirati Therapeutics IncMRTX | 6 | Strong Buy | $71.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 3 | Hold | $228.00 | N/A | Maintains | 4 years ago |
Zymeworks IncZYME | 1 | Hold | $9.00 | N/A | Maintains | 4 years ago |
Arcturus Therapeutics Holdings IncARCT | 5 | Hold | $25.00 | N/A | Upgrades | 4 years ago |
Orchard Therapeutics PLCORTX | 2 | Strong Buy | $40.00 | N/A | Maintains | 4 years ago |
Meiragtx Holdings PLCMGTX | 1 | Strong Buy | $18.00 | N/A | Maintains | 4 years ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $48.00 | N/A | Maintains | 4 years ago |
Decibel Therapeutics IncDBTX | 2 | Strong Buy | $7.00 | N/A | Maintains | 5 years ago |
Sigilon Therapeutics IncSGTX | 1 | Strong Buy | $91.00 | N/A | Maintains | 5 years ago |
Logicbio Therapeutics IncLOGC2 | 1 | Strong Buy | $8.00 | N/A | Maintains | 5 years ago |
Axonics IncAXNX1 | 1 | Strong Buy | $197.50 | N/A | Maintains | 5 years ago |
Aceragen IncACGN | 1 | Hold | $2.00 | N/A | Downgrades | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Strong Sell | $45.00 | N/A | Downgrades | 7 years ago |
Tesaro IncTSRO | 1 | Hold | $75.00 | N/A | Downgrades | 8 years ago |
Puma Biotechnology IncPBYI | 5 | Strong Sell | $29.00 | N/A | Downgrades | 8 years ago |
Spark Therapeutics IncONCE | 4 | Strong Buy | $77.00 | N/A | Maintains | 8 years ago |
Avexis IncAVXS | 3 | Hold | N/A | N/A | Downgrades | 9 years ago |
Juno Therapeutics IncJUNO | 2 | Hold | N/A | N/A | Downgrades | 9 years ago |
Cascadian Therapeutics IncCASC | 1 | Strong Sell | $4.00 | N/A | Initiates Coverage On | 9 years ago |
Abeona Therapeutics IncABEO | 1 | Strong Buy | $275.00 | N/A | Initiates Coverage On | 10 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.